Pfizer was granted a patent for multi-antigen pneumococcal vaccines

{
  "signal_id": "37f16bfb-1bc9-59fd-9867-e65f66be7a72",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-10-29T23:54:35+00:00",
  "company": {
    "name": "Pfizer",
    "domain": "pfizer.com"
  },
  "data": {
    "cpc": [
      {
        "code": "A61K 39/092"
      },
      {
        "code": "A61K 47/646"
      },
      {
        "code": "A61P 31/00"
      },
      {
        "code": "A61K 2039/6037"
      },
      {
        "code": "A61K 2039/645"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Pharmaceuticals",
      "Healthcare Technology"
    ],
    "detail": "In October 2026 Pfizer patented conjugate vaccine formulations for preventing pneumococcal infections in people, particularly infants and older adults.",
    "summary": "Pfizer was granted a patent for multi-antigen pneumococcal vaccines",
    "event_at": "2026-10-27",
    "inventors": [
      {
        "name": "Avvari Krishna Prasad",
        "status": "unresolved",
        "is_primary": true
      },
      {
        "name": "Jianxin Gu",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/jianxin-gu-44675017"
      },
      {
        "name": "Jin-Hwan Kim",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/jin-hwan-kim-3a325616"
      },
      {
        "name": "Suddham Singh",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/suddham-singh-a349ab1a"
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-10-27",
    "source_url": "https://patents.google.com/patent/US12773447",
    "cpc_primary": {
      "code": "A61K 39/092"
    },
    "patent_title": "Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof",
    "patent_number": "US12773447",
    "uspto_assignee": "Pfizer Inc.",
    "patent_abstract": "The present invention relates to new glycoconjugates comprising Streptococcus pneumoniae capsular saccharide antigens and uses thereof. Glycoconjugates of the present invention will typically comprise 2 or more saccharides antigens conjugated to the same molecule of the protein carrier. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumoccocal infections using immunogenic compositions comprising said novel glycoconjugates.",
    "precision_class": "structural",
    "invention_explanation": "A vaccine design that links multiple pneumococcal sugar antigens to one protein so the immune system can recognize and respond to them.",
    "technologies_mentioned": [
      "conjugate vaccines",
      "pneumococcal vaccines",
      "immunology"
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/37f16bfb-1bc9-59fd-9867-e65f66be7a72 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"pfizer.com","limit":20}'